As an extra meeting place between exhibitors, visitors & press located on the show floor, speakers will be presenting the industry about their products, services, new launches, innovations and news. These sessions are free to attend to all visitors to CPhI Korea and co-located events.

2022 Technical Seminar Agenda

09.28(Wed) Seminar Room A
2022 기술세미나 스케줄
Session Number Time Title Organisation / Company Speaker
D-1 11:00 - 11:30 Ensure Data Integrity by Digitizing Quality and Manufacturing Master Control Ciaran O’Keeffe, Channel Sales Director
D-5 13:30 - 16:10 Successful New Drug Development and Commercialization Strategy
- the case study of the 'BIG3 project' by Ministry of SMEs and Startups -
Korea Institute of Toxicology
13:30 - 13:40 Introduction
13:40 - 14:00 Interim Report on the 'Bio R&D and Commercialization Strategy Boot-camp' Chemon Co., Ltd Yeong-Chul Park, Head
14:00 - 14:50 A lot of obstacles in a view of toxicity test for IND approval
14:50 - 15:00 Breaktime
15:00 - 15:20 Explanation of the entire curriculum from the basic stage of securing(acquirement of technology) IP to legal dispute cases for Big 3 Beyond Lab Co., Ltd Lee Young-Gu, CEO
15:20 - 16:10 Features and properties of patent and technolgy licensing in Biology area Institute for Basic Science, Innovation Team YOU ByoungDon, Patent attorney
09.28(Wed) Seminar Room B
Session Number Time Title Organisation / Company Speaker
G-1 11:00 - 12:10 Seminar: Business and Investment Opportunities in Developing Countries
English&Korean
UNIDO(United Nations Industrial Development Organization)
11:00 - 11:30 Seminar: Business and Investment Opportunities in Azerbaijan State Tax Service under the Ministry of Economy, Legal Department BADALOVA KONUL, Chief Lawyer
11:40 - 12:10 Seminar: Business and Investment Opportunities in Bangladesh Statistics & Informatics Division, Ministry of Planning AZIM ALIMUL, Accounts Officer
G-5 13:30 - 14:00 Chinese FSMP market demand and certification,New product registration in Hainan Maris Group Korea Jany Kim, Deputy Department Head
G-6 13:30 - 16:10 The launching ceremony for 'Bio-health Industry-Academic-Research collaboration platform' by the Ministry of SMEs and Startups
13:30 - 13:40 Introduction to the R&D collaboration project Korea Institute of Toxicology
13:40 - 14:00 Introduction to the program to accelerate cooperation among the organizations in charge
14:00 - 14:50 Detailed guidelines for the project
- with the explanation on the business expenses -
14:50 - 15:00 Breaktime
15:00 - 15:20 Draft Roadmap of the 'R&D collaboration project'
15:20 - 16:10 Project schedules and details
09.29(Thur) Seminar Room A
2022 기술세미나 스케줄
Session Number Time Title Organisation / Company Speaker
E-1 10:15 - 10:45 Lipid Excipients as Enhancers for Transdermal Drug Delivery
English
Gattefosse Asia Pacific Pte. Ltd Dr. Hongyi Ouyang
E-2 11:00 - 11:45 Compritol® 888 ATO – A Multi-functional and Versatile Excipient for Sustained Release, Dual Matrix and Lubrication
English
Gattefosse Asia Pacific Pte. Ltd Dr. Hongyi Ouyang
E-4 12:50 - 13:20 Integrated Drug Discovery Services
(Integrated analytical technologies and services by Concept Life Sciences)
English
Malvern Panalytical Michael Caves, Business Development Manager
E-5 13:30 - 16:00 Response to the Non-Clinical SEND for Global Licencing
- the case study of the 'BIG3 project', by Ministry of SMEs and Startups -
13:30 - 13:40 Introduction Korea Institute of Toxicology
13:40 - 14:00 CDISC Data Strategy for Global Clinical Trial Market after SEND Creation Cluppy Co., Ltd Gihwan Kim, CEO
14:00 - 14:40 The current status of data standards by the U.S. FDA Korea Institute of Toxicology Heeyoung Jang, Researcher
14:40 - 14:50 Breaktime
14:50 - 15:30 A case on the SEND applied by the participant company Connext Co., Ltd Donghoon Cho, Chairman
15:30 - 16:00 The current use of KIT's SEND. Korea Institute of Toxicology Yoongi Kim, Senior Researcher
09.29(Thur) Seminar Room B
2022 기술세미나 스케줄
Session Number Time Title Organisation / Company Speaker
H-2 11:00 - 11:30 A customized functional Exosome, Reprosome Stemon KIM SOON HAG, CEO
H-3 11:40 - 12:10 Introducing nutritional approaches to support women's health : Graminex Pollen Extracts
English
Graminex Korea
Graminex LLC
Dr. Sun Ho Frank Kim, Managing Director
Dr. Alex Grantz, Chief Scientific Officer
H-5 12:50 - 13:20 Innovation that transforms lives - Oligonucleotide manufacturing at Bachem
English
Bachem Japan Aya Ito, Business Development Manager
H-6 13:30 - 16:40 Functional food material and patent briefing session and conference Rural Development Administration & Korea Agriculture Techonology Promotion Agency
Technology transfer procedure guide / Introduction of technology commercialization support project The Korea Agriculture Technology Promotion Agency, Tech transfer team KIM JUNKI, Researcher
Ⅰ: Composition for improvement, prevention or treatment of colitis comprising extract of radish sprouts as an active ingredient National Institute of Agricultural Sciences KIM KI CHANG, Researcher
Ⅱ: A composition for enhancing Innate immunity using fermented Acanthopanax sessiliflorum fruit as an active ingredient National Institute of Horticultural and Herbal Science, Industrial Crop Utilization Division KIM GWAN WOO, Reseaercher
Ⅲ: Antidiabetic red bean extract composition for lowering blood glucose level and increasing diet effect National Institute of Crop Science, Unpland Crop Breeding Division LEE BYUNG WON, Researcher
Ⅳ: Anti-obesity composition comprising Betaone unhulled grain extract as effective component National Institute of Crop Science, Crop Doundation Division LEE MI JA, Researcher
Composition for improving hair loss and promoting hair growth containing extracts of oat National Institute of Crop Science, Crop Doundation Division SEO WOO DEOK, Researcher
H-9 15:10 - 15:40 Usage of mass-produced minor ginsenosides as the functional ingredients for natural medicine and health supplementary foods AceEMzyme Wan Taek Im, CEO
09.30(Fri) Seminar Room A
2022 기술세미나 스케줄
Session Number Time Title Organisation / Company Speaker
F-1 10:20 - 12:10 Strategy for IP Transfer and Commercialization Korea Invention Promotion Association
10:20 - 10:40 IP Transfer Office introduction & Techonology commercialization strategy Korea Invention Promotion Association, IP Transfer Office Kim Hyun Myeong, Senior Specialist for Patent Transactions
10:40 - 11:00 State-owned patent system introduction Korea Invention Promotion Association, IP Transfer Office Lee Do Won, Section Manager
11:00 - 11:10 Development of fundamental technology for rare diseases in muscle area Korea University College of Medicine, Department of Anatomy Kim Hyeon Soo, Professor
11:10 - 11:20 Diagnostic methods of liver diseases, diabetes, hyperlipidemia for Koreans using genetic information National Institute of Health, Division of Genome Science Kim Young Jin, Senior Staff Scientist
11:20 - 11:30 Development of diagnostic and therapeutic agents for intestinal infection bacteria National Institute of Health, Division of Zoonotic and Vector Borne Diseases Seung-Hak Cho, Researach Scientist
11:30 -11:40 Recombinant adenovirus using an epitope of Ag85B, method for preparing the same and vaccine composition for preventing tuberculosis comprising the same National Institute of Health, Division of Infecious Disease Vaccine Research Hye-Sook Jeong, Senior Staff Scientist
11:40 - 11:55 Introduction to the Super-Satellite Marker Search Approach Using Next Generation Sequencing Method and Explanation of Similar Patents Biopharmaceutical research department of the Food and Drug Safety Evaluation Institute Lee Woo-gyu, Health Researcher
11:55 - 12:10 Introduction to immunogenicity measurement methods and explanation of the features of the technology Dentak Research institue, SNU Jang seong-ho, Professor
F-5 13:00 - 13:30 Session 1. Introduction of ASEAN-Korea Cooperation in Health Ministry of Health and Welfare 윤찬식 국제협력국장
13:30 - 13:35 Break Time
13:35 – 14:00 Session 2. Introduction of ASEAN Bio and Pharceutial market and business partnership with Korea Malaysian Investment Development Authority, MIDA TBD
14:00 - 14:25 Session 3-1. Case study: Joint venture/business case of ASEAN-Korea Bio Industry (Thailand) KinGen Biotech Panit Kitsubun, Chief Operating
14:25 - 14:50 Session 3-2. Case study: Joint venture/business case of ASEAN-Korea Bio Industry (Indonesia) Kgbio Indonesia Jimmy Susanto, VP
14:50 - 15:00 QnA
09.30(Fri) Seminar Room B
2022 기술세미나 스케줄
Session Number Time Title Organisation / Company Speaker
I-1 10:30 - 12:30 Technology and Patent Trends in the field of Health Functional Food (esp. about Oral & Hair Care) Korea Institute of Intellectual Property Promotion Song Young Hun, Team Manager
I-5 13:00 - 15:30 Seminar: Business and Investment Opportunities in Developing Countries
English&Korean
UNIDO(United Nations Industrial Development Organization)
13:00 - 13:30 Seminar: Business and Investment Opportunities in Azerbaijan Main Department of National Revenues of the State Tax Service ALIZADA ISMAYIL, State Tax Inspector
13:40 - 14:10 Seminar: Business and Investment Opportunities in Tunisia Presidency of the Tunisia Government BEJAOUI MEHER, Head of Services-Advisor of Public Services
14:20 - 15:50 Seminar: Business and Investment Opportunities in Kenya Kenya Revenue Authority ING'AHIZU DORIS, Assistant Manager

* The above timetable is subject to change without prior notice by the organiser or speakers
** All sessions will be held in Korean unless marked 'English'